At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 125 enrolled
Drug / intervention
UNR844-Cl +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A 3-month, Randomized, Placebo-controlled, Double-masked, Multi-center Study to Evaluate the Safety and Efficacy of Topical Ocular UNR844-Cl in Subjects With Presbyopia
In Brief
A Phase 2 clinical trial evaluating UNR844-Cl and Placebo for Presbyopia. Completed, enrolled 125 participants across 14 sites.
Detailed Summary
The purpose of this study was to assess the effect of topical UNR844-Cl (lipoic acid choline ester chloride) ophthalmic solution on near visual function in presbyopic subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20192020202120222023202420252026
First PostedJan 2019
Enrollment StartApr 2019
Primary CompletionDec 2019
TodayJul 2026
First PostedJan 18, 2019
Enrollment StartApr 26, 2019
Primary CompletionDec 16, 2019
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 7.5 years ago
Interventions
UNR844-Cldrug
1.5% Ophthalmic solution for topical ocular administration
Placebodrug
placebo